These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19089580)

  • 21. Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients.
    Vasilij Benatti S; Giampaolo Q; Sara B; Marco R; Diego R
    AIDS; 2014 Nov; 28(17):2633-5. PubMed ID: 25574965
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin].
    Merino Rodríguez B; Díaz Sánchez A; Matilla Peña A; Clemente Ricote G; Núñez Martínez O
    Gastroenterol Hepatol; 2008 Jan; 31(1):18-21. PubMed ID: 18218275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
    Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citalopram-associated central retinal vein occlusion.
    Hardisty AD; Hemmerdinger CM; Quah SA
    Int Ophthalmol; 2009 Aug; 29(4):303-4. PubMed ID: 18545940
    [No Abstract]   [Full Text] [Related]  

  • 25. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thyroid alterations following treatment with pegylated interferon and ribavirin: differences between HIV-coinfected and non-coinfected patients].
    Montes-Ramírez ML; Rodríguez-Zapata M
    Enferm Infecc Microbiol Clin; 2006 Mar; 24(3):213-4. PubMed ID: 16606567
    [No Abstract]   [Full Text] [Related]  

  • 27. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
    Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Listeria monocytogenes meningitis in a patient with chronic hepatitis C infection, treated by interferon alfa and ribavirin.
    Vander T; Medvedovsky M; Hallevy C; Golzman G; Herishanu Y
    J Infect; 2003 Jan; 46(1):70-1. PubMed ID: 12504615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 30. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
    Lai CH; Yang YH; Chen PC; King YC; Liu CY
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):191-198. PubMed ID: 29210149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
    Oiso N; Sato M; Kawada A
    J Dermatol; 2013 Sep; 40(9):772-3. PubMed ID: 23855823
    [No Abstract]   [Full Text] [Related]  

  • 32. Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C.
    Borghi-Scoazec G; Merle P; Scoazec JY; Claudy A; Trepo C
    J Hepatol; 2004 May; 40(5):871-2. PubMed ID: 15094241
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

  • 34. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
    Callens S; Bottieau E; Michielsen P; Colebunders R
    AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].
    Chebil A; Kort F; Bouraoui R; Youssef NB; El Matri L
    J Fr Ophtalmol; 2010 Mar; 33(3):185-8. PubMed ID: 20172621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.
    Marcoval J; Notario J; Martín C; Gómez S
    Actas Dermosifiliogr; 2014 Mar; 105(2):211-2. PubMed ID: 23623282
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C; Pérez-Álvarez R
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.
    Wendling J; Descamps V; Grossin M; Marcellin P; Le Bozec P; Belaich S; Crickx B
    Arch Dermatol; 2002 Apr; 138(4):546-7. PubMed ID: 11939833
    [No Abstract]   [Full Text] [Related]  

  • 39. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
    Lin J; Lott JP; Amorosa VK; Kovarik CL
    J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
    [No Abstract]   [Full Text] [Related]  

  • 40. Segmental vitiligo and hair curling after interferon alpha and ribavirin treatment for hepatitis C.
    Tinio P; Hadi S; Al-Ghaithi K; Al-Qari H; Rudikoff D
    Skinmed; 2006; 5(1):50-1. PubMed ID: 16522988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.